BackgroundKey components of Ending the HIV Epidemic (EHE) plan include increasing HIV antiretroviral therapy (ART) and HIV pre-exposure prophylaxis (PrEP) coverage. One complication to addressing this service delivery challenge is the wide heterogeneity of HIV burden and health care access across the United States. It is unclear how the effectiveness and efficiency of expanded PrEP will depend on different baseline ART coverage.MethodsWe used a network-based model of HIV transmission for men who have sex with men (MSM) in San Francisco. Model scenarios increased varying levels of PrEP coverage relative under current empirical levels of baseline ART coverage and 2 counterfactual levels. We assessed the effectiveness of PrEP with the cumulati...
International audienceObjectives: To study the conditions under which PrEP coverage can eliminate HI...
Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention i...
Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention i...
ObjectivesIdentifying prescribing strategies that improve the efficiency of PrEP should increase its...
It remains unclear what proportions of HIV-infected and uninfected people should receive effective a...
Preexposure prophylaxis (PrEP) is a promising intervention to help end the HIV epidemic among men wh...
Introduction: Once-daily tenofovir/emtricitabine-based pre-exposure prophylaxis (PrEP) can reduce HI...
IntroductionLong-acting injectable cabotegravir (CAB-LA) demonstrated superiority to daily tenofovir...
OBJECTIVE: Preexposure prophylaxis (PrEP) is a promising intervention to help end the HIV epidemic a...
Pre-exposure prophylaxis (PrEP) effectively reduces human immunodeficiency virus (HIV) transmission....
Early diagnosis and treatment of HIV infection and suppression of viral load are potentially powerfu...
Abstract Background Poor adherence to either antiretroviral treatment (ART) or pre-exposure prophyla...
Early diagnosis and treatment of HIV infection and suppression of viral load are potentially powerfu...
BackgroundDespite continued reductions in the number of HIV cases reported among San Francisco men w...
Introduction HIV prevalence is high among men who have sex with men (MSM) in Baltimore, Maryland, Un...
International audienceObjectives: To study the conditions under which PrEP coverage can eliminate HI...
Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention i...
Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention i...
ObjectivesIdentifying prescribing strategies that improve the efficiency of PrEP should increase its...
It remains unclear what proportions of HIV-infected and uninfected people should receive effective a...
Preexposure prophylaxis (PrEP) is a promising intervention to help end the HIV epidemic among men wh...
Introduction: Once-daily tenofovir/emtricitabine-based pre-exposure prophylaxis (PrEP) can reduce HI...
IntroductionLong-acting injectable cabotegravir (CAB-LA) demonstrated superiority to daily tenofovir...
OBJECTIVE: Preexposure prophylaxis (PrEP) is a promising intervention to help end the HIV epidemic a...
Pre-exposure prophylaxis (PrEP) effectively reduces human immunodeficiency virus (HIV) transmission....
Early diagnosis and treatment of HIV infection and suppression of viral load are potentially powerfu...
Abstract Background Poor adherence to either antiretroviral treatment (ART) or pre-exposure prophyla...
Early diagnosis and treatment of HIV infection and suppression of viral load are potentially powerfu...
BackgroundDespite continued reductions in the number of HIV cases reported among San Francisco men w...
Introduction HIV prevalence is high among men who have sex with men (MSM) in Baltimore, Maryland, Un...
International audienceObjectives: To study the conditions under which PrEP coverage can eliminate HI...
Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention i...
Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention i...